RIGL
Rigel Pharmaceuticals, Inc. · Healthcare · Biotechnology
Input momentum (manajer yang sebanding):
keluasan pemegang -12.5% ·
aliran saham +9.9% ·
posisi baru bersih -14.3%
— formula
Akumulasi terkonsentrasi — peningkatan saham di antara lebih sedikit pemegang
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q1 2025
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 72 | -2 | 9.47M | $370.29M | +3 | −5 |
| Q1 2026 | 77 | -10 | 11.13M | $301.00M | — | −10 |
| Q4 2025 | 86 | +1 | 11.49M | $491.92M | +1 | — |
| Q3 2025 | 18 | +3 | 6.87M | $194.53M | +3 | — |
| Q2 2025 | 12 | +2 | 4.47M | $83.70M | +2 | — |
| Q1 2025 | 7 | -1 | 1.55M | $27.81M | +2 | −3 |
| Q4 2024 | 8 | +4 | 1.41M | $23.66M | +5 | −1 |
| Q3 2024 | 3 | -2 | 554.02K | $8.97M | — | −2 |
| Q2 2024 | 5 | — | 605.71K | $4.98M | — | — |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (pasif) | 637.03K | +67.4% | $11.46M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (pasif) | 411.17K | +2.3% | $7.40M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 3 | Geode Capital Management ✦ (pasif) | 411.17K | +2.3% | $7.40M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Marshall Wace ✦ | 211.75K | Baru | $3.81M | 0.0% | New | 1 | SEC ↗ |
| 5 | Marshall Wace ✦ | 211.75K | Baru | $3.81M | 0.0% | New | 1 | SEC ↗ |
| 6 | Renaissance Technologies ✦ | 201.15K | -32.9% | $3.62M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 7 | Wellington Management ✦ | 61.40K | +75.5% | $1.10M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | Wellington Management ✦ | 61.40K | +75.5% | $1.10M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | Two Sigma Investments ✦ | 12.68K | -79.2% | $228,077 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 10.63K | Baru | $191,162 | 0.0% | New | 1 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 10.63K | Baru | $191,162 | 0.0% | New | 1 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 10.63K | Baru | $191,162 | 0.0% | New | 1 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 10.63K | Baru | $191,162 | 0.0% | New | 1 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 10.63K | Baru | $191,162 | 0.0% | New | 1 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Marshall Wace | $3.81M | 0.0% |
| Marshall Wace | $3.81M | 0.0% |
| AQR Capital Management | $191,162 | 0.0% |
| AQR Capital Management | $191,162 | 0.0% |
| AQR Capital Management | $191,162 | 0.0% |
| AQR Capital Management | $191,162 | 0.0% |
| AQR Capital Management | $191,162 | 0.0% |
Telah keluar
| Norges Bank | $2.18M | adalah 0.0% |
| Millennium Management | $1.18M | adalah 0.0% |
| Citadel Advisors | $477,873 | adalah 0.0% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 146 pemegang, 15.81M saham, $391.97M dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.